Results 1 to 13 of 13
Page 1 of 1
TypeTitleAuthor(s)YearViews
CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survivalHe, WP; Zhou, J; Cai, MY; Xiao, XS; Liao, YJ; Kung, HF; Guan, X; Xie, D; Yang, GF201213
 
EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherinTong, ZT; Cai, MY; Wang, XG; Kong, LL; Mai, SJ; Liu, YH; Zhang, HB; Liao, YJ; Zheng, F; Zhu, W; Liu, TH; Bian, XW; Guan, XY; Lin, MC; Zeng, MS; Zeng, YX; Kung, HF; Xie, D2012192
 
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2Zheng, F; Liao, YJ; Cai, MY; Liu, YH; Liu, TH; Chen, SP; Bian, XW; Guan, XY; Lin, MC; Zeng, YX; Kung, HF; Xie, D2012224
 
Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradationZhang, B; Qian, D; Ma, HH; Jin, R; Yang, PX; Cai, MY; Liu, YH; Liao, YJ; Deng, HX; Mai, SJ; Zhang, H; Zeng, YX; Lin, MC; Kung, HF; Xie, D; Huang, JJ2012128
 
Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransitionZhu, W; Cai, MY; Tong, ZT; Dong, SS; Mai, SJ; Liao, YJ; Bian, XW; Lin, MC; Kung, HF; Zeng, YX; Guan, XY; Xie, D2012175
 
EZH2 protein: A promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsiesCai, MY; Tong, ZT; Zheng, F; Liao, YJ; Wang, Y; Rao, HL; Chen, YC; Wu, QL; Liu, YH; Guan, XY; Lin, MC; Zeng, YX; Kung, HF; Xie, D2011398
 
EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β 1 and is a predictor of outcome in ovarian carcinoma patientsRao, ZY; Cai, MY; Yang, GF; He, LR; Mai, SJ; Hua, WF; Liao, YJ; Deng, HX; Chen, YC; Guan, XY; Zeng, YX; Kung, HF; Xie, D2010198
 
Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosisWang, Y; Liu, YH; Mai, SJ; He, LJ; Liao, YJ; Deng, HX; Guan, XY; Zeng, YX; Kung, HF; Xie, D2010588
 
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapyHe, LR; Liu, MZ; Li, BK; Jia, WH; Zhang, Y; Liao, YJ; Chen, YC; Zhang, LJ; Guan, XY; Zeng, YX; Kung, HF; Xie, D2010485
 
Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinomaHe, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Zhang, LJ; Guan, XY; Zeng, YX; Xie, D2009122
 
Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinomaWu, GQ; Xie, D; Yang, GF; Liao, YJ; Mai, SJ; Deng, HX; Sze, J; Guan, XY; Zeng, YX; Lin, MC; Kung, HF2009254
 
Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladderLuo, JH; Hua, WF; Rao, HL; Liao, YJ; Kung, HF; Zeng, YX; Guan, XY; Chen, W; Xie, D2009138
 
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinomaHe, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Guan, XY; Zeng, YX; Xie, D2009188
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download